Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
The inclusion of KPV is a key differentiator
Each received a daily subcutaneous injection for one year: half (102) received up to 1.8 mg of liraglutide and half (102) received a placebo
LC-MS and peptide mapping remain essential for identity, sequence confirmation and impurity characterization
Patient has a BMI (body mass index) of 27 or higher and at least one weight-related health condition like diabetes, high blood pressure, heart disease, or sleep apnea
E.ChopraH.RahmanM
US$ 22.84
US$ 23.25
US$ 27.72
US$ 24.59
US$ 25.02
US$ 28.38
US$ 27.48
US$ 27.34
US$ 26.78
US$ 24.11
US$ 20.88
